Uncategorized - July 22, 2020
U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 […]
Read More
Uncategorized - July 22, 2020
PETAH TIKVA, Israel, July 22, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in […]
Read More
Uncategorized - July 22, 2020
Daniel M. Skovronsky, M.D., Ph.D. Elected to Myriad’s Board of Directors. Walter (Wally)Gilbert, Ph.D., announces upcoming retirement from the Board […]
Read More
Uncategorized - July 22, 2020
GOLETA, Calif., July 22, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]
Read More
Uncategorized - July 22, 2020
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]
Read More
Uncategorized - July 22, 2020
FDA feedback allows for forward program developmentCompany reiterates that its favorable safety profile and its advanced manufacturing and analytics capabilities […]
Read More
Uncategorized - July 22, 2020
LAFAYETTE, La., July 22, 2020 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) today announced details for the release of […]
Read More
Uncategorized - July 22, 2020
WOBURN, Mass., July 22, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies […]
Read More
Uncategorized - July 22, 2020
Phase 2/3 study process initiated in Brazil and Mexico The global Phase 2/3 study with opaganib in patients with severe COVID-19 […]
Read More
Uncategorized - July 22, 2020
Second quarter 2020 net revenues1 were $699 million, an increase of 12% over the second quarter of 2019. Compared to […]
Read More